Shareholders of Whitehawk Therapeutics (NASDAQ: WHWK) approve directors, pay and auditor
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Whitehawk Therapeutics, Inc. reported the results of its 2026 annual meeting of stockholders, where investors voted on director elections, executive pay and the company’s auditor. A total of 40,375,023 common shares, representing approximately 82% of voting power as of April 17, 2026, were present, establishing a quorum.
Stockholders elected three Class III directors – Behzad Aghazadeh, Ph.D., Richard Maroun and Emma Reeve – to terms ending at the 2029 annual meeting. On an advisory basis, stockholders approved the compensation of named executive officers. They also ratified the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares represented at meeting: 40,375,023 shares
Voting power represented: approximately 82%
Votes for Behzad Aghazadeh, Ph.D.: 26,666,124 votes
+4 more
7 metrics
Shares represented at meeting
40,375,023 shares
Common stock present or by proxy at 2026 annual meeting
Voting power represented
approximately 82%
Voting power of issued and outstanding common stock as of April 17, 2026
Votes for Behzad Aghazadeh, Ph.D.
26,666,124 votes
For election as Class III director at 2026 annual meeting
Votes for Richard Maroun
27,701,332 votes
For election as Class III director at 2026 annual meeting
Votes for Emma Reeve
27,704,564 votes
For election as Class III director at 2026 annual meeting
Say-on-pay votes for
22,896,061 votes
Advisory approval of named executive officer compensation
Auditor ratification votes for
34,795,850 votes
Ratification of BDO USA, P.C. for fiscal year ending December 31, 2026
Key Terms
broker non-votes, advisory basis, independent registered public accounting firm, quorum, +1 more
5 terms
broker non-votes financial
"Director | For | Withheld | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory basis financial
"to approve, on an advisory basis, the compensation of the named executive officers"
independent registered public accounting firm financial
"the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
quorum financial
"constituting a quorum for the transaction of business, were present in person or by proxy"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What did Whitehawk Therapeutics (WHWK) stockholders vote on at the 2026 annual meeting?
Stockholders voted on three key items: electing three Class III directors, approving executive compensation on an advisory basis, and ratifying BDO USA, P.C. as independent auditor for the fiscal year ending December 31, 2026. All three proposals received sufficient support to pass.
Were the Class III directors elected at Whitehawk Therapeutics’ 2026 meeting, and how many votes did they receive?
All three Class III director nominees were elected. Behzad Aghazadeh, Ph.D. received 26,666,124 votes for, Richard Maroun received 27,701,332, and Emma Reeve received 27,704,564. Each director also recorded withheld votes and 7,841,674 broker non-votes associated with the election proposal.
Did Whitehawk Therapeutics (WHWK) stockholders ratify BDO USA, P.C. as auditor for 2026?
Yes. Stockholders ratified the appointment of BDO USA, P.C. as independent registered public accounting firm for the year ending December 31, 2026. The ratification received 34,795,850 votes for, 1,148,282 against, and 4,430,891 abstentions, indicating strong support for retaining the audit firm.
What was Proposal 2 at Whitehawk Therapeutics’ 2026 annual meeting?
Proposal 2 asked stockholders to approve, on an advisory basis, the compensation of named executive officers listed in the 2025 Summary Compensation Table. It passed with 22,896,061 votes for, 6,013,600 against, and 3,623,688 abstentions, plus 7,841,674 broker non-votes recorded on the proposal.